Visceral leishmaniasis in clinical practice.
Davidson
R N
RN
Department of Infectious Diseases and Tropical Medicine, Lister Unit, Northwick Park Hospital, Harrow, Middlesex, UK.
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy / Q000503:physiopathology; D000818:Animals; D000967:Antimony Sodium Gluconate / Q000191:economics / Q000494:pharmacology / Q000627:therapeutic use; D000981:Antiprotozoal Agents / Q000191:economics / Q000494:pharmacology / Q000627:therapeutic use; D004351:Drug Resistance; D005260:Female; D006801:Humans; D016867:Immunocompromised Host; D007891:Leishmania / Q000187:drug effects; D007898:Leishmaniasis, Visceral / Q000188:drug therapy / Q000276:immunology / Q000503:physiopathology*; D008297:Male; D008536:Meglumine / Q000191:economics / Q000494:pharmacology / Q000627:therapeutic use; D000077485:Meglumine Antimoniate; D009942:Organometallic Compounds / Q000191:economics / Q000494:pharmacology / Q000627:therapeutic use
D000981:Antiprotozoal Agents; D009942:Organometallic Compounds; D008536:Meglumine; D000077485:Meglumine Antimoniate; D000967:Antimony Sodium Gluconate